Lexaria Bioscience Corp. (LEXX)
11.01
+0.47
(+4.46%)
USD |
NASDAQ |
Aug 25, 13:05
Lexaria Bioscience 1 Year Total Returns (Daily) : -11.37% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -11.37% |
| August 21, 2026 | -7.41% |
| August 20, 2026 | -6.01% |
| August 19, 2026 | -9.62% |
| August 18, 2026 | -8.19% |
| August 17, 2026 | -16.05% |
| August 14, 2026 | -24.57% |
| August 13, 2026 | -34.94% |
| August 12, 2026 | -51.05% |
| August 11, 2026 | -53.01% |
| August 10, 2026 | -56.69% |
| August 07, 2026 | -57.67% |
| August 06, 2026 | -57.57% |
| August 05, 2026 | -57.05% |
| August 04, 2026 | -57.18% |
| August 03, 2026 | -62.76% |
| July 31, 2026 | -56.56% |
| July 30, 2026 | -56.69% |
| July 29, 2026 | -40.39% |
| July 28, 2026 | -39.65% |
| July 27, 2026 | -46.68% |
| July 24, 2026 | -44.65% |
| July 23, 2026 | -44.64% |
| July 22, 2026 | -42.33% |
| July 21, 2026 | -41.99% |
| Date | Value |
|---|---|
| July 20, 2026 | -36.54% |
| July 17, 2026 | -26.89% |
| July 16, 2026 | -35.70% |
| July 15, 2026 | -27.80% |
| July 14, 2026 | -29.60% |
| July 13, 2026 | -32.47% |
| July 10, 2026 | -28.16% |
| July 09, 2026 | -30.58% |
| July 08, 2026 | -31.25% |
| July 07, 2026 | -39.36% |
| July 06, 2026 | -37.83% |
| July 02, 2026 | -34.51% |
| July 01, 2026 | -32.71% |
| June 30, 2026 | -35.63% |
| June 29, 2026 | -33.02% |
| June 26, 2026 | -38.34% |
| June 25, 2026 | -37.42% |
| June 24, 2026 | -42.42% |
| June 23, 2026 | -41.32% |
| June 22, 2026 | -39.29% |
| June 18, 2026 | -45.98% |
| June 17, 2026 | -38.95% |
| June 16, 2026 | -41.68% |
| June 15, 2026 | -37.94% |
| June 12, 2026 | -39.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Target Group, Inc. (Canada) | -38.82% |
| InMed Pharmaceuticals, Inc. | -37.28% |
| NervGen Pharma Corp. | -21.26% |
| Milestone Pharmaceuticals, Inc. | -38.82% |
| Clearmind Medicine, Inc. | -99.59% |